DENNIS G. PODLESAK

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Syndax Pharmaceuticals Inc

Filing Date Source Excerpt
2017-04-07 "Mr. Podlesak received a B.A. and an M.B.A. from Pepperdine University..."
2018-04-10 "Mr. Podlesak received a B.A. and an M.B.A. from Pepperdine University, and has completed postgraduate studies at the Wharton School, University of Pennsylvania."
2019-04-30 "Mr. Podlesak received a B.A. and an M.B.A. from Pepperdine University, and has completed postgraduate studies at the Wharton School, University of Pennsylvania."
2020-04-29 Mr. Podlesak received a B.A. and an M.B.A. from Pepperdine University, and has completed postgraduate studies at the Wharton School, University of Pennsylvania.
2021-04-01 "Mr. Podlesak is the Chief Executive Officer and Managing Partner of Canaan Partners’ Axceliux LLC... Mr. Podlesak received a B.A. and an M.B.A. from Pepperdine University..."
2022-03-29 "Mr. Podlesak received a B.A. and an M.B.A. from Pepperdine University, and has completed postgraduate studies at the Wharton School, University of Pennsylvania."
2023-04-07 "Mr. Podlesak received a B.A. and an M.B.A. from Pepperdine University, and has completed postgraduate studies at the Wharton School, University of Pennsylvania."
2024-04-02 "Mr. Podlesak received a B.A. and an M.B.A. from Pepperdine University, and has completed postgraduate studies at the Wharton School, University of Pennsylvania."
2025-04-01 "Mr. Podlesak received a B.A. and an M.B.A. from Pepperdine University, and has completed postgraduate studies at the Wharton School, University of Pennsylvania."

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-09